Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis 2024-03-18 19:25
KeChow Pharma Announces NMPA Approval of Tunlametinib (HL-085) as the First Targeted Therapy for Patients with NRAS Mutated Advanced Melanoma and Previously Treated with PD-1/PD-L1 2024-03-18 18:02
ImmVira's oncolytic product MVR-T3011 IT Intratumoral Injection Receives FDA Fast Track Designation for HNSCC Treatment 2024-03-15 13:56
Biotheus Expanded Their Partnership with Hansoh Pharma for Developing EGFR/cMET Bispecific Antibody-Drug Conjugates 2024-03-15 12:34
I-Mab Reports Full Year 2023 Financial Results and Business Update 2024-03-15 05:00
D3 Bio Appoints Dr. Antoine Yver as Independent Board Member 2024-03-14 22:30
Study of Kintor's c-Myc Degrader Published in Subsidiary Journal of Nature 2024-03-14 12:22
YolTech Therapeutics to Showcase Breakthroughs in in vivo Gene Editing at TIDES Asia 2024 2024-03-13 20:00
Sanyou Biopharmaceuticals Launches Advanced Intelligent R&D Service Platform 2024-03-13 09:00
Mabwell to Present Pre-clinical Results at the 2024 American Association for Cancer Research (AACR) Annual Meeting 2024-03-12 22:00
GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30% 2024-03-12 20:15
Longbio Pharma Presented Positive Phase 1 Results for LP-003 at 2024AAD 2024-03-12 20:00
Mabwell to Present ADC Platform IDDC™ and the Latest Study Results of Multiple Novel ADCs at the 14th World ADC London 2024-03-11 22:00
Medicilon has appointed Dr. Qingcong Lin as President of Medicilon USA Corp., further deepening the global strategic layout 2024-03-11 20:30
Mabwell to Present the Clinical Data of 9MW2821 in Cervical Cancer as Focused Plenary Oral Presentation at 2024 Society of Gynecologic Oncology Annual Meeting on Women's Cancer 2024-03-08 22:00
TransThera Announced Global Phase 3 Clinical Trial for Cholangiocarcinoma Authorized in the European Union and Orphan Drug Designation for Tinengotinib to Treat Biliary Tract Cancer Granted by European Medicines Agency 2024-03-08 21:00
Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry 2024-03-07 22:00
AACR 2024 | Ascentage Pharma to Present Three Preclinical Studies at 2024 American Association of Cancer Research Annual Meeting 2024-03-06 08:59
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries 2024-03-05 21:00
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment 2024-03-05 21:00
1 5 6 7 8 9 204